ANTI-VIRAL AGENT - ITO EN LTD

Title:

ANTI-VIRAL AGENT

Document Type and Number:

WIPO Patent Application WO/2022/102590

Kind Code:

A1

Abstract:

Provided is an anti-viral agent, and in particular, an anti-viral agent for coronaviruses such as SARS-CoV-2. This anti-viral agent contains a tea component.

More Like This:

WO/2018/214412	TRADITIONAL CHINESE MEDICINE COMPOSITION COMPRISING DRIED TANGERINE PEELS AND DARK TEA FOR TREATING DIABETES AND PREPARATION METHOD THEREOF
WO/2018/088566	THERAPEUTIC OR PROPHYLATIC DRUG FOR ISCHEMIC DISEASE, GLAUCOMA, OPTIC NERVE DISEASE, RETINAL DEGENERATIVE DISEASE, ANGIOGENIC RETINAL DISEASE, CANCER, NEURODEGENERATION, OR AUTOIMMUNE DISEASE, AND HYPOXIA INDUCIBLE FACTOR INHIBITOR
JP2002370973	PATCH AGENT OF CRUDE MEDICINE

Inventors:

MAZDA OSAM (JP)
OHGITANI ERIKO (JP)
SHIN-YA MASAHARU (JP)
ICHITANI MASAKI (JP)
KOBAYASHI MAKOTO (JP)
TAKIHARA TAKANOBU (JP)
KINUGASA HITOSHI (JP)

Application Number:

PCT/JP2021/041065

Publication Date:

May 19, 2022

Filing Date:

November 09, 2021

Export Citation:

Click for automatic bibliography generation Help

Assignee:

ITO EN LTD (JP)
KYOTO PREFECTURAL PUBLIC UNIV CORP (JP)

International Classes:

A61K36/82; A23L2/52; A23L33/105; A61K8/49; A61K31/353; A61P31/12; A61P31/14; A61Q19/10; C07D311/62

Foreign References:

JP2018024610A

2018-02-15

Other References:

GHOSH KALYAN; AMIN SK. ABDUL; GAYEN SHOVANLAL; JHA TARUN: "Chemical-informatics approach to COVID-19 drug discovery: Exploration of important fragments and data mining based prediction of some hits from natural origins as main protease (Mpro) inhibitors", JOURNAL OF MOLECULAR STRUCTURE, ELSEVIER AMSTERDAM, NL, vol. 1224, 5 August 2020 (2020-08-05), NL , XP086376829, ISSN: 0022-2860, DOI: 10.1016/j.molstruc.2020.129026
JANG MINSU, PARK YEA-IN, CHA YEO-EUN, PARK RACKHYUN, NAMKOONG SIM, LEE JIN I., PARK JUNSOO: "Tea Polyphenols EGCG and Theaflavin Inhibit the Activity of SARS-CoV-2 3CL-Protease In Vitro", EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, OXFORD UNIVERSITY PRESS, US, vol. 2020, 17 September 2020 (2020-09-17), US , pages 1 - 7, XP055929397, ISSN: 1741-427X, DOI: 10.1155/2020/5630838

Attorney, Agent or Firm:

SAEGUSA & PARTNERS (JP)

Download PDF:

View/Download PDF PDF Help

Previous Patent: IMAGE PROCESSING DEVICE FOR ESTIMATING CONDITION INSIDE ORAL CAVITY OF PATIENT, AND PROGRAM AND METH...

Next Patent: NON-AQUEOUS ELECTROLYTE STORAGE ELEMENT, AND NON-AQUEOUS ELECTROLYTE STORAGE DEVICE